跳至主要内容
临床试验/NCT03713216
NCT03713216已完成4 期

Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy

Cathay General Hospital1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2018年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
44
试验地点
1
主要终点
Postoperative pain score

研究概览

简要总结

To determine the effect and safety of NALDEBAIN versus Morphine as needed in patients after laparoscopic cholecystectomy.

详细描述

This is an open-labeled, randomized clinical trial. Group A will receive one dose of NALDEBAIN before surgery. Group B will receive morphine as needed. Pain will be assessed for PACU, 4, 24, 48, 72 hours after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female with 20 years old or older.
  • Scheduled to electively undergo laparoscopic cholecystectomy.
  • Ability and willingness to provide informed consent.

排除标准

  • Not willing to adhere to the study visit schedule and complete all study assessments.
  • History of hypersensitivity or allergy to opioid, or NSAIDs or sesame oil.
  • Any clinically significant condition that may interfere with study assessments or compliance.
  • Pregnant or breastfeeding.
  • Medical history may cause abnormal intracranial pressure.
  • History of dependency, addiction, and withdrawal for narcotic drugs.

研究组 & 干预措施

Naldebain

Experimental

Subjects will receive one dose of Naldebain before surgery.

干预措施: Naldebain (Drug)

Morphine

Active Comparator

Subjects will receive morphine after surgery.

干预措施: Morphine (Drug)

结局指标

主要结局

Postoperative pain score

时间窗: 24 hours after surgery

Using visual analog scale (VAS) with grades from 0 (no pain) to 10 (worst pain)

次要结局

  • Consumption of supplemental analgesics(From Day 0 to Day 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验